Abstract
We have shown that the pulsing of dendritic cells (DCs) with human papillomavirus type 16 (HPV-16) antigen proteins by lipofection stimulates class I–restricted cytotoxic T lymphocyte (CTL) response against primary cervical cancer cells. Also, we have shown that adeno-associated virus (AAV) was able to effectively deliver a cytokine gene into DCs. It has been our hypothesis that the delivery of antigen genes into DCs, resulting in endogenous and continuous antigen protein expression, may result in an improvement in T-cell priming by DCs. Here, DCs are pulsed (infected) with an AAV vector containing the HPV-16 E6 gene. After infection, transduced E6 gene mRNA expression and vector chromosomal integration could be identified in infected DCs. Furthermore, priming rosettes formed at early times when the AAV/E6 vector was used. Most importantly, AAV/E6 vector pulsing of DCs induced, after only 7 days of priming, a strong CTL response against primary cervical cancer cell lines, compared to bacterial E6 protein lipofection. Killing was significantly blocked by the addition of anti-MHC class I antibodies. Fluorescence-activated cell sorter (FACS) analysis of resulting primed cell populations revealed higher levels of CD8+ T cells by AAV-based pulsing, with little evidence of CD56 (NK). FACS analysis of the DC populations revealed that AAV/E6 vector–pulsed DCs had higher levels of CD80 and lower levels of CD86 than protein-pulsed DCs. These data suggest that rAAV may be appropriate for antigen pulsing of DCs for immunotherapy protocols. Finally, our protocol represents an advance in regards to the time needed for generating a CTL response compared to other techniques. Cancer Gene Therapy (2001) 8, 948–957
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steinman RA . The dendritic cell system and its role in immunogenicity Annu Rev Immunol 1991 9: 271–296
Sallusto F, Lanzavecchia A . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha J Exp Med 1994 179: 1109–1118
Romani N, Gruner S, Brang D, et al . Proliferating dendritic cell progenitors in human blood J Exp Med 1994 180: 83–93
Young JW, Inaba K . Dendritic cells as adjuvants for class I major histocompatibility complex–restricted antitumor immunity J Exp Med 1996 183: 7–11
Zivotgel L, Mayordomo JI, Tjandrawan T, et al . Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation and T helper cell I–associated cytokines J Exp Med 1996 183: 87–97
Paglia P, Chiodoni C, Rhodolfo M, Colombo MP . Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo J Exp Med 1996 183: 317–322
Alexander M, Salgaller M, Leseban C, Barnes WA, Rosenberg SA, Steller MA . Generation of tumor-specific cytotoxic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope Am J Obstet Gynecol 1996 175: 1586–1593
Philip R, Brunette E, Ashton J, et al . Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors Cancer Gene Ther 1998 5: 236–246
McArthur JG, Mulligan RC . Induction of protective anti-tumor immunity by gene-modified dendritic cells J Immunother 1998 21: 41–47
Fields RC, Shimizu K, Mule JJ . Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo Proc Natl Acad Sci USA 1998 95: 9482–9487
Sonderbye L, Feng S, Yacoubian S, et al . In vivo and in vitro modulation of immune stimulatory capacity of primary dendritic cells by adenovirus-mediated gene transduction Exp Clin Immunogenet 1998 15: 100–111
Kim CJ, Prevette T, Cormier J, et al . Dendritic cells infected with poxviruses encoding mart-1/melan a sensitize T lymphocytes in vitro J Immunother 1997 20: 276–286
Peshwa MV, Shi JD, Ruegg C, Laus R, Van Schooten WC . Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide Prostate 1998 36: 129–138
Dematos P, Abdel-Wahab Z, Vervaert C, Hester D, Seigler H . Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against b16 tumors in mice J Surg Oncol 1998 74: 79–91
Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E . Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA Nature Biotechnology 1998 16: 364–369
Tjandrawan T, Martin DM, Maeurer MJ, et al . Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro J Immunother 1998 21: 149–157
Barratt-Boyes SM, Kao H, Finn OJ . Chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo J Immunother 1998 21: 142–148
Tuting T, Wilson CC, Martin DM, et al . Autologous human monocyte–derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro : enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and TFN-alpha J Imm 1998 160: 1139–1147
De Bruijn ML, Schuurhuis DH, Vierboom MP, et al . Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I–restricted protection to HPV16-induced tumor cells Can Res 1998 58: 724–731
Tsai V, Kawashima I, Keogh E, Daly K, Sette A, Celis E . In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells Crit Rev Immunol 1998 18: 65–75
Wong C, Morse M, Nair SK . Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides J Immunol 1998 21: 32–40
Alters SE, Gadea JR, Sorich M, O'Donoghue G, Talib S, Philip R . Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire J Immunol 1998 21: 17–26
Navabi H, Jasani B, Adams M, et al . Generation of in vitro autologous human cytotoxic T-cell response to E7 and her-2/neu oncogene products using ex-vivo peptide loaded dendritic cells Adv Exp Med Biol 1997 417: 583–589
Specht JM, Wang G, Do MT, et al . Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases J Exp Med 1997 186: 1213–1221
Toujas L, Delcros JG, Diez E, et al . Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA Class I–restricted exogenous peptides Immunology 1997 91: 635–642
Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ . Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL J Immunol 1997 158: 3270–3276
Tsai V, Southwood S, Sidney J, et al . Identification of subdominant CTL epitopes of the gp100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells J Immunol 1997 158: 1796–1802
Hermans IF, Daish A, Moroni-Rawson P, Ronchese F . Tumor-peptide–pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge Can Immunol, Immunother 1997 44: 341–347
Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu P . Retroviral transduction of human dendritic cells with a tumor-associated antigen gene Can J Res 1996 56: 5672–5677
Smith CA, Woodruff LS, Kitchingman GR, Rooney CM . Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro J Virol 1996 70: 6733–6740
Van Elsas A, Van der Burg SH, van der Minne CE, et al . Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A0201–binding peptides from the melan-a/mart-1 self antigen Eur J Immunol 1996 26: 1683–1689
Bianchi R, Grohmann U, Belladonna ML, et al . IL-12 is both required and sufficient for initiating T cell reactivity to a class I–restricted tumor peptide (p815ab) following transfer of p815ab-pulsed dendritic cells J Immunol 1996 157: 1589–1597
Mjaaland S, Fossum S . Dendritic leucocytes pulsed with monoclonal antibody–hapten conjugates elicit vigorous primary humoral responses in vivo Scand J Immunol 1995 41: 305–308
Santin AD, Hermonat PL, Ravaggi A, et al . Generation of an MHC class I restricted cytotoxic T cell response against autologous cervical cancer tumor cells by lipofection of synthetic human papillomavirus types 16 and 18 E7 protein into primary dendritic cells J Virol 1999 73: 5402–5410
Santin AD, Hermonat PL, Ravaggi A, et al . Development, characterization, and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus E7 Eur J Gynaecol Oncol 2000 21: 17–23
Smotkin D, Wettstein FO . The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein J Virol 1987 61: 1686–1689
Liu Y, Santin AD, Mane M, et al . Transduction and utility of the granulocyte macrophage–colony stimulating factor gene into monocytes and dendritic cells by adeno-associated virus J Interferon Cytokine Res 2000 20: 21–30
Hermonat PL, Muzyczka N . Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells Proc Natl Acad Sci USA 1984 81: 6466–6470
Laface D, Hermonat PL, Wakeland EK, Peck AB . Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector Virology 1988 162: 483–486
Zhou SZ, Broxmeyer HE, Cooper S, Harrington MA, Srivastava A . Adeno-associated virus 2–mediated gene transfer in murine hematopoietic progenitor cells Exp Hematol 1993 21: 928–933
Zhou SZ, Cooper S, Kang LY, et al . Adeno-associated virus 2–mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood J Exp Med 1994 179: 1867–1875
Goodman S, Xiao X, Donahue RE, et al . Recombinant adeno-associated virus–mediated gene transfer into hematopoietic progenitor cells Blood 1994 84: 1492–1500
Podsakoff G, Wong KK Jr, Chatterjee S . Efficient gene transfer into nondividing cells by adeno-associated virus–based vectors J Virol 1994 74: 5656–5666
Chiorini JA, Wendtner CM, Urcelay E, Safer B, Hallek M, Kotin RM . High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors Hum Gene Ther 1995 6: 1531–1541
Lubovy M, McCune S, Dong JY, Prchal JF, Townes TM, Prchal JT . Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients Biol Blood Marrow Transplant 1996 2: 24–30
Fisher-Adams G, Wong KK Jr, Podsakoff G, Forman SJ, Chatterjee S . Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction Blood 1996 88: 492–504
Ponnazhagan S, Mukherjee P, Wang XS, et al . Adeno-associated virus type 2–mediated transduction in primary human bone marrow–derived Cd34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation J Virol 1997 71: 8262–8267
Ponnazhagan S, Yoder MC, Srivastava A . Adeno-associated virus type 2–mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo J Virol 1997 71: 3098–3104
Hermonat PL, Quirk JG, Bishop BM, Han L . Packaging capacity of adeno-associated virus and the potential for wild type-plus AAV gene therapy vectors FEBS Lett 1997 407: 78–84
Auricchio A, Hildinger M, O'Connor E, Gao G-P, Wilson JM . Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column Hum Gene Ther 2001 12: 71–76
Pala P, Verhoef A, Lamb JR, Openshaw PJ . Single cell analysis of cytokine expression kinetics by human CD4+ T-cell clones during activation or tolerance induction Immunology 2000 100: 209–216
Bennet SRM, Carbone FR, Karamalis F, Miller JFAP, Health WR . Induction of CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help J Exp Med 1997 186: 65–70
Clerici M, Shearer GM, Clerici E . Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the Th1/Th2 paradigm J Natl Can Inst 1997 90: 261–263
Nitta T, Yagita H, Sato K, Okumura K . Involvement of CD56 (NKh-1/leu-19 antigen) as an adhesion molecule in natural killer–target cell interaction J Exp Med 1989 170: 1757–1761
Hilders CGJM, Ras L, van Eendenburg JDH, Nooyen Y, Fleuoren GJ . Isolation and characterization of tumor-infiltrating lymphocytes from cervical cancer Int J Cancer 1994 57: 805–813
Nonacs R, Humborg C, Tam JP, Steiman RM . Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific cytolytic T lymphocytes J Exp Med 1992 176: 519–529
Hoggan MD, Thomas G, Johnson FB . Continuous carriage of adenovirus associated virus genome in cell culture in the absence of helper adenovirus In Proceedings of the Fourth Lepetite Colloquium, Cocoyac, Mexico Amsterdam: North-Holland 1972 pp. 243–249
Cheung AKM, Hoggan MD, Hauswirth WW, Berns KI . Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells J Virol 1980 33: 739–746
Laughlin CA, Cardellichio CB, Coon HC . Latent infection of kb cells with adeno-associated virus type 2 J Virol 1986 60: 515–522
Masten BJ, Yates JL, Pollard Koga AM, Lipscomb ME . Characterization of accessory molecules in murine lung dendritic cell function: roles of CD80, CD86, CD54, and CD40L Am J Respir Cell Mol Biol 1997 16: 335–342
Acknowledgements
Drs. Yong Liu and Maurizio Chiriva-Internati contributed equally to this work. We acknowledge the excellent assistance provided by Teri Fields and Rena Sheffer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Chiriva-Internati, M., Grizzi, F. et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther 8, 948–957 (2001). https://doi.org/10.1038/sj.cgt.7700391
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700391
Keywords
This article is cited by
-
A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade
Journal of Translational Medicine (2019)
-
Alterations of dendritic cell subsets in the peripheral circulation of patients with cervical carcinoma
Journal of Experimental & Clinical Cancer Research (2010)
-
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function
Cancer Immunology, Immunotherapy (2010)
-
Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation
Journal of Translational Medicine (2009)
-
Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells
Journal of Translational Medicine (2008)